Search

for
Search:

Research

5 / 877 results

research A woman with iatrogenic androgenetic alopecia responding to finasteride

13 citations , February 2007 in “British Journal of Dermatology”

EF and PXE not closely related.

research Iatrogenic androgenetic alopecia in a male phenotype 46XX true hermaphrodite

July 2011 in “British Journal of Dermatology”

Hormone treatment caused hair loss, finasteride helped regrowth.

research When Microneedling Backfires: A Hidden Risk of Hair Shaft Fragility in AGA Patients

January 2026 in “Journal of Cosmetic Dermatology”

This study observed that repeated low-depth microneedling in patients with androgenetic alopecia led to initial hair improvement but subsequently caused hair-shaft fragility and breakage, suggesting iatrogenic damage.

Testosterone Enantate Induced Androgenetic Alopecia in a 46XX True Hermaphrodite

research Testosterone enantate

May 2012 in “Reactions Weekly”

A man developed hair loss from testosterone treatment but improved with additional medication.

research Neuroendokrine paraneoplastische Syndrome

March 2021 in “Der Hautarzt”

This review covers the clinical features, pathophysiology, differential diagnoses, and therapeutic options for neuroendocrine paraneoplastic syndromes affecting the skin but reports no new clinical findings.

View more "iatrogenic androgenetic alopecia" in research →

Community Join

5 / 1000+ results

community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

63 upvotes 2 years ago

Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

View more "iatrogenic androgenetic alopecia" in community →

Learn

9 / 801 results

learn Finasteride

Frontline, gold standard treatment for combatting androgenic alopecia

learn Alopecia Areata

autoimmune disorder causing patchy hair loss

learn Botox

What’s the science behind Botox injections for androgenetic alopecia? Small published studies and a 2025 meta-analysis report hair-count gains from scalp botulinum toxin injections, but nearly all of them lack control groups, and reviewers of the same literature call the evidence low-quality; the treatment is off-label and not approved for hair loss anywhere.

learn TDM-105795

What types of alopecia or hair loss conditions might TDM-105795 be designed to target based on current research? TDM-105795 may target non-scarring alopecia, particularly androgenetic alopecia.

learn Alfatradiol

Alfatradiol: What does a form of estrogen have to do with hair loss in men? Alfatradiol (17α-estradiol) is a prescription topical hormone, licensed for androgenetic alopecia in Germany but not FDA-approved. The controlled trial evidence is in women, where it produced stabilisation rather than regrowth and was outperformed by minoxidil; no comparable placebo-controlled trial in men appears to have been published.

learn GT20029

research compound made to degrade androgen receptors in scalp

Is GT20029 safe and effective for both men and women with androgenic alopecia? Not yet. GT20029 is an experimental drug: early trials suggest it is well tolerated, but its effectiveness and long-term safety are unproven, especially in women.